← Leaderboards
William Perry Janzen
Univ Of North Carolina Chapel Hill
$939,584
Attributed
$1,806,277
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $733.7K · FY2010–14$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,806,277 · 6
By mechanism
R01$1,004,192 · 2
R21$729,195 · 3
R03$72,890 · 1
Top collaborators
- Miriam S. Braunstein2 shared
- Paul A Dayton2 shared
- Rudolph Juliano1 shared
- Ronald I Swanstrom1 shared
- Cyrus Vaziri1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Cyrus Vaziri$12,585,722
- Michael Luca Durando$155,497
- Cary A Moody$8,050,523
- Robert J Duronio$13,776,855
- Kent Rossman$1,611,025
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseProteinsHigh Throughput ScreeningBiologyInhibitor/AntagonistPharmaceutical PreparationsCellsDrug DiscoveryMalignant NeoplasmsChromatinAssay DevelopmentReadingCancer TherapyScreening ProcedureCancer CellBinding (Molecular Function)InnovationSmall MoleculeMono-SLibrariesLipidsMutationLaboratoriesGenome
Grant awards (9)
Targeting the TLS DNA Damage Tolerance Pathway for Cancer Therapy$286,392
R01 · FY2014 · GM
Developing High-Throughput Assays for M. tuberculosis Tat Pathway Inhibitors$347,800
R01 · FY2013 · AI
Cavitation Enhancement of Biospecimen processing for Improved DNA Fragmentation$217,535
R21 · FY2013 · CA · contact PI
Developing High-Throughput Assays for M. tuberculosis Tat Pathway Inhibitors$370,000
R01 · FY2012 · AI
Cavitation Enhancement of Biospecimen processing for Improved DNA Fragmentation$198,360
R21 · FY2012 · CA · contact PI
Addressing Undruggable Targets Using Oligonucleotides and Small Molecules (PQ18)$165,300
R21 · FY2012 · CA
High Throughput Screen For HIV-1 MA/CA Processing Site Inhibitors$148,000
R21 · FY2011 · NS
High-Throughput Screening for the Discovery of Novel Scaffolds that Anatagonize M$35,890
R03 · FY2011 · DA · contact PI
High-Throughput Screening for the Discovery of Novel Scaffolds that Anatagonize M$37,000
R03 · FY2010 · DA · contact PI